Results 11 to 20 of about 157,661 (308)
Arteriosclerosis, Thrombosis, and Vascular Biology, 2006 The obesity pandemic will likely have a significant impact on the global incidence of cardiovascular disease. Although the mechanisms linking obesity and cardiovascular disease are unclear, recent studies have implicated the adipocyte as a potentially important mediator of vascular complications.
Peter F. Bodary, Daniel T. Eitzman
+6 more sources
Stroke, 2005 Despite efforts at controlling traditional risk factors, stroke remains a devastating and all-too-common disease. Identifying new markers for patients at higher risk of stroke would aid in future risk factor management as well as potentially offering new venues for preventive therapies.
Miwa, Ryo, Tohru, Funahashi
openaire +4 more sources
International Journal of Noncommunicable Diseases, 2022 The biological functioning of adiponectin (APN) has been well understood for two decades. Numerous clinical and animal studies have paved an understanding of the exposed physiological functions of APN in obesity and its related disorders. APN mediates its action through its receptors to achieve its function.
Geetha Bhaktha +2 more
openaire +2 more sources
Adiponectin and Adiponectin Receptors [PDF]
Endocrine Reviews, 2005 Metabolic syndrome is thought to result from obesity and obesity-linked insulin resistance. Obesity in adulthood is characterized by adipocyte hypertrophy. Adipose tissue participates in the regulation of energy homeostasis as an important endocrine organ that secretes a number of biologically active "adipokines."Heterozygous peroxisome proliferator ...
Takashi, Kadowaki, Toshimasa, Yamauchi
openaire +2 more sources
Circulation Research, 2016 Adiponectin is the most adipocyte-specific of all secretory factors described to date. Despite its exclusive expression at the level of the fat cell, adiponectin concentrations in plasma are generally inversely proportional to fat mass.1,2 More detailed studies reveal that it is not fat mass, but rather fat quality that is the driving force for ...
Mala Sharma +2 more
+6 more sources
Frontiers in Endocrinology, 2013 High molecular weight (HMW) adiponectin levels are reduced in humans with type 2 diabetes and insulin resistance. Similar to humans with insulin resistance, managed bottlenose dolphins (Tursiops truncatus) diagnosed with hemochromatosis (iron overload ...
Benjamin A Neely +5 more
doaj +1 more source
Circulating High-Molecular-Weight (HMW) Adiponectin Level Is Related with Breast Cancer Risk Better than Total Adiponectin: A Case-Control Study. [PDF]
PLoS ONE, 2015 The level of total adiponectin, a mixture of different adiponectin forms, has been reported associated with breast cancer risk with inconsistent results. Whether the different forms play different roles in breast cancer risk prediction is unclear.
Ming-ming Guo +32 more
doaj +1 more source
Association between circulating adiponectin levels and polycystic ovarian syndrome [PDF]
, 2014 Background: Low adiponectin levels in polycystic ovarian syndrome (PCOS) have been largely attributed to obesity which is common among these patients. In addition, evidence also suggests that low adiponectin in PCOS may be related to insulin resistance (
Khan, Naveed Ali +4 more
core +3 more sources
Role of the adiponectin binding protein, T-cadherin (Cdh13), in allergic airways responses in mice. [PDF]
PLoS ONE, 2012 Adiponectin is an adipose derived hormone that declines in obesity. We have previously shown that exogenous administration of adiponectin reduces allergic airways responses in mice.
Alison S Williams +9 more
doaj +1 more source